Gene delivery into cells offers opportunities to treat various human genetic disease. Effective gene delivery is dependent on its stability and ability to transfect across cells. DNA is susceptible to enzymatic degradation and its negatively charge are barriers towards successful transfection. DNA has to be protected from degradation and neutralised. Non-viral vectors are preferred carrier systems, therefore, the use of cyclodextrins with Pluronic®-F127 and folic acid at different concentrations to stabilise the formulation was investigated. Formulations were characterised in fresh and freeze dried forms. DNA stability in formulations was tested by determining the stability of DNA against enzymatic degradation. Degree of DNA inclusion into cyclodextrins was investigated using fluorescence spectroscopy. Thermal behaviour was studied using Differential Scanning Calorimetry (DSC). Incorporation of Pluronic®-F127 produced most stable formulations regarding enzymatic degradation. These formulations show high percentage inclusion. Shift of peaks in FTIR data, appearance of uniform particulate as detected by SEM and changing in the denaturation temperature as demonstrated by DSC data for Pluronic®-F127 containing formulations confirm clear interaction between Pluronic®-F127 and cyclodextrin/ DNA complex. It was noted that γ-cyclodextrin provide better protection and inclusion compared to β-cyclodextrin. Pluronic®-F127 with cyclodextrins is a promising combination to improve stability.
|Journal||Current Pharmaceutical Biotechnology|
|Publication status||Published (in print/issue) - 2014|
Bibliographical noteReference text:  Anchordoquy, J.T., Allison, S.D., Molina, M.d.C., Girouard ,L.G.,
Carson, T.K. Physical stabilization of DNA-based therapeutics.
Drug Discovery Today. 2001; 6: 463-470.
 Niidome, T., Huang, L. Gene Therapy Progress and Prospects:
Nonviral Vectors. Gene Therapy (Nature) 2002; 9: 1647-1652.
 Wong, S.Y., Pelet, J.M., Putnam, D. Polymer systems for gene
delivery- past, present and future. Progress in Polymer Science.
2007; 32: 799-837.
 Park, T.G., Jeong, J.H., Kim, S.W. Current status of polymeric
gene delivery systems. Advanced Drug Delivery Reviews. 2006;
58: 467- 486.
 Abdelhady, H.G., Allen, S., Davies, M.C., Roberts, C.J., Tendler,
S.J., Williams, P.M. Direct real-time molecular scale visualisation
of the degradation of condensed DNA complexes exposed to
DNase I. Nucleic Acids Research. 2003; 31: 4001-4005.
 Lechardeur, D., Sohn, K-J., Haardt, M., Joshi, P.B., Monck, M.,
Graham, R.W., Beatty, B., Squire, J. H., O’Brodovich, Lukacs,
G.L. Metabolic instability of plasmid DNA in the cytosol: a potential
barrier to gene transfer. Gene Therapy. 1999; 6: 482-497.
 Brown, M.D., Schatzlein, A.G., Uchegbu, I.F. Gene delivery with
synthetic (non viral) carriers. Int. J. Pharm. 2001; 229: 1-21.
 Schaffer, D.V., Lauffenburger, D.A. Optimization of Cell Surface
Binding Enhances Efficiency and Specificity of Molecular Conjugate
Gene Delivery. J. Biol. Chem. 1998; 273: 28004-28009.
 Herweijer, H., Wolff, J.A. Progress and prospects: naked DNA
gene transfer and therapy. Gene Therapy (Nature). 20003; 10: 453-
 Williamson, J.F. Advances and Perspectives in intracellular biomolecule
delivery. Pharmaceutical Technology Europe 2008.
 Well, D.J. Review Gene Therapy Progress and Prospects: Electroporation
and other physical methods. Gene Therapy (Nature). 2004;
 Huang, L., Li, S. Non-viral gene therapy: promises and challenges.
Gene Therapy (Nature). 2000; 7: 31-34.
 David, M.E. Non-viral gene delivery systems. Curr. Opin. Biotech.
2002; 13: 28-131.
 Lv, H., Zhang, S., Wang, B., Cui, S., Yan, J. Toxicity of cationic
lipids and cationic polymers in gene delivery. J. Cont. Release.
2006; 114: 100-109.
 Del Valle, E.M.M. Cyclodextrins and their uses: a review. Process
Biochem. 2004; 39: 1033-1046.
 Loftsson, T. Cyclodextrins I: Physicochemical Properties and in
vitro Evaluation. AAPS Webinar 2011.
 Rasheed, A., Kumar, A., Sravanthi, V. V. N. S. S. Cyclodextrins as
Drug Carrier Molecule: A Review. Sci Pharm. 2008; 76: 567-598.
 Szejtli, J. Medicinal applications of cyclodextrins. Medicinal Research Reviews. 1994; 14: 353-386.
 Stella, V.J., Rajeswski, R.A. Cyclodextrins: Their future in drug
formulations and delivery. Pharm. Res. 1997; 14: 556-567.
 Burckbuchler, V., Wintgens, V., Leborgne, C., Lecomte, S., Leygue,
N., Scherman, D., Kichler, A., Amiel, C. Development and
Characterization of New Cyclodextrin Polymer-Based DNA Delivery
Systems. Bioconjugate Chemistry. 2008; 19(12): 2311-2320.
 Strappe, P.M., Hampton, D.W., Cachon-Gonzalez, B., Fawcett,
J.W., Lever, A. Delivery of a lentiviral vector in a Pluronic F127
gel to cells of the central nervous system. Eur. J. Pharm. Biopharm.
2005; 61: 126-133.
 Guo, W., Lee, R.L. Receptor-targeted gene delivery via folate
conjugated polyethylenimine. AAPS PharmSci. 1999; 1(4).
 Lyscov, V., N., Moshkovsky, Y.,S. DNA cryolysis. Biochim. Biophy.
Acta. 1969; 190: 101-110.
 Maitani, Y., Asob, Y., Yamadaa, A., Yoshioka, S. Effect of sugars
on storage stability of lyophilized liposome/DNA complexes with
high transfection efficiency. Int. J. Pharm. 2008; 356: 69-75.
 Anchordoquy, T.J., Giourourard, L.G., Carpenter, J.F., Kroll, D.J.
Stability of lipid/DNA complexes during agitation and freezethawing.
J. Pharm. Sci. 1988; 87: 1046-1051.
 Shikama, K. Effect of freezing and thawing on the stability of
double helix of DNA. Nature 1965; 207: 529-530.
 Talsma, H., Cherng, J.Y., Lehrmann, H., Kursa, M., Ogris, M.,
Hennink, W.E., Cotton, M., Wagner, E. Stabilization of gene delivery
systems by freeze-drying. Int. J. Pharm. 1997; 157: 233-238.
 Cryan,S.A., Holohan, A., Donhue, R., Darcy, R., O’Driscoll. Cell
transfection with polycationic cyclodextrin vectors. Eur. J. Pharm.
Sci. 2004; 21: 625-633.
 Cooper, A., Nutley, M.A., Wadood, A. Differential scanning microcalorimetry.
In S. E. Harding and B. Z. Chowdhry (Eds.), Protein-
Ligand Interactions: hydrodynamics and calorimetry. Oxford
University Press, Oxford New York, 2000; 287-318.
 Rengarajan, K., Cristol, S.M., Mehta, M., Nickerson, J.M. Quantifying
DNA concentrations using fluorometry: A comparison of
fluorophores. Molecular Vision. 2002; 8: 416-421.
 Li, B., Li, S., Tan, Y., Stolz, D.B., Watkins, S.C., Block, L.H.
Lyophilization of cationic lipid-protamine- DNA (LPD) complexes.
J. Pharm. Sci. 2000; 89: 355-364.
 Pozo-Rodríguez, A.D., Solinís, M.A., Gascón, A.R., PedrazShort,
J.L. Short and long-term stability study of lyophilized solid lipid
nanoparticles for gene therapy. Eur. J. Pharm. Biopharm. 2009; 71:
 Beba, H.M., Elkordy, A.A. Carrier systems in gene delivery - progressive
research in mental health pharmacy. Clinical Pharmacist.
2011; 3 (3): S2-S3.
 Zhang, Y., Lam, Y.M. Study of Mixed Micelles and Interaction
Parameters for Polymeric Nonionic and Normal Surfactants,
American Scientific Publishers. 2006; 6: 1-5.
 Linse, P. Micellization of poly(ethylene oxide)-poly(propylene
oxide) triblock copolymers in aqueous solution. Macromolecules.
1993; 26: 4437-4449
 Bohorqueza, M., Kocha, M., Trygstadb, T., abd Pandit, N. Study of
the Temperature-Dependent Micellization of Pluronic F127. J. Colloid
and Interface Science. 1999; 216: 34-40.
 Mao, Y., Daniel, L.N., Whittaker, N., Saffiottil, U. DNA Binding
to Crystalline Silica Characterized by Fourier-Transform Infrared
Spectroscopy. Environmental Health Perspectives 1993.
 Ruiz-Chica, A.J., Khomutov, A.R., Medina, M.A., Sanchez-
Jimenez, F., Ramirez, F.J. Interaction of DNA with an aminooxy
analogue of spermidine Ð an FT-IR and FT-Raman approach. J.
Molecular Structure. 2001; 565; 253-258.
 Ouameur, A.A., Tajmir-Riah, H.A. Structural Analysis of DNA
Interactions with Biogenic Polyamines and Cobalt(III) hexamine
Studied by Fourier Transform Infrared and Capillary Electrophoresis.
J. Biol. Chem. 2004; 279(40): 42041-42054.
- deoxyribonucleic acid (DNA)
- DNA degradation
- gene delivery
- non-viral vectors